×
0 0 0 0 0 0 -0.00595238095238104 -0.0119047619047619
Stockreport

Acorda Presenting New Tozadenant Data at 2017 MDS Congress

ACORDA THERAPEUTICS (ACOR)  More Company Research Source: Business Wire
Last acorda therapeutics earnings: 2/15 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) is presenting new data from clinical and preclinical studies of tozadenant at the 2017 International Congress of Parkinson’s Disease and Movement Disorders (MDS), being held in Vancouver, British Columbia from June 4-8, 2017. Acorda is developing tozadenant as a daily maintenance therapy to reduce OFF time for people with Parkinson’s taking an oral carbidopa / levodopa regimen. OFF refers to the re-emergence of Parkinson’s symptoms. “OFF is cited by people with Parkinson’s as one of the most challenging aspects of their disease to manage,” said Burkhard Blank, M.D., Acorda’s Chief Medical Officer. “Tozadenant represents a potential first-in-class treatment for Parkinson’s in the U.S. that is being studied to reduce overall daily OFF time.” Tozadenant data being presented at the MDS congress include: Ass [Read more]

IMPACT SNAPSHOT EVENT TIME: ACOR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS